SUMMIT, N.J. — Kenvue Inc., the consumer health giant behind household names like Tylenol, Neutrogena, and Listerine, has earned a spot on the prestigious Fortune 500 list for the first time, less than two years after becoming a fully independent company. Ranked No. 281, the company secured its position with $15.5 billion in 2024 revenue, signaling strong early performance in the competitive consumer health sector.
The company stated that the milestone reflects Kenvue’s rapid rise since its spin-off from Johnson & Johnson, showcasing the strength of its global portfolio and commitment to science-backed, consumer-focused innovation.
“Being named to the Fortune 500 list marks a significant milestone for Kenvue,” said CEO Thibaut Mongon in a statement. “Recognitions like this validate the hard work and dedication of our Kenvuers, while also further propelling our desire to become the undisputed global leader in consumer health.”
With operations in over 165 countries and a workforce of more than 20,000 employees—referred to internally as “Kenvuers”—the company delivers a wide array of products across Essential Health, Self Care, and Skin Health & Beauty categories. Kenvue estimates its brands reach approximately 1.2 billion people daily.
The company has framed its strategy around combining scientific rigor with deep consumer insights, aiming to meet the rising demand for wellness-driven products and routines. Executives say Kenvue’s placement on the Fortune 500 is not just a financial achievement but also a launchpad for deeper influence in the global health and wellness space.
The Fortune 500, now in its 71st year, ranks U.S. companies by total revenues and is widely regarded as a benchmark of corporate scale and influence. Kenvue’s debut places it among the largest public and private enterprises in the country, underscoring the power of its brand portfolio and global footprint.
Kenvue noted that it is the largest pure-play consumer health company in the world by revenue. Its products—sold under such brand names as Aveeno, BAND-AID, Johnson’s, Listerine, Neutrogena, and Tylenol—are frequently recommended by healthcare professionals and have become staples in homes around the globe.
As it continues its growth trajectory, Kenvue is positioning itself to play a leading role in what it calls the “wellness revolution,” using its scale and scientific foundation to shape the future of everyday care.
